PSYCHOMETRIC HEPATIC ENCEPHALOPATHY SCORE FOR THE DIAGNOSIS OF MINIMAL HEPATIC ENCEPHALOPATHY IN ROMANIAN CIRRHOTIC PATIENTS - PARTIAL RESULTS

Authors

  • M.A. BADEA University of Medicine and Pharmacy “Grigore T. Popa”- Iasi
  • Cristina CIJEVSCHI-PRELIPCEAN University of Medicine and Pharmacy “Grigore T. Popa”- Iasi
  • Catalina MIHAI University of Medicine and Pharmacy “Grigore T. Popa”- Iasi
  • Iolanda POPA University of Medicine and Pharmacy “Grigore T. Popa”- Iasi
  • V.L. DRUG University of Medicine and Pharmacy “Grigore T. Popa”- Iasi

Abstract

In Romania, minimal hepatic encephalopathy (MHE) is underdiagnosed and undertreated in patients with liver cirrhosis. The psychometric hepatic encephalopathy score (PHES) is recommended as the first-line tool for the diagnosis of MHE. Aim: To use PHES in a group of Romanian cirrhotic patients and highlight the relationships between demographic and biological factors and tests results. Materials and Methods:  Of the 148 patients with liver cirrhosis admitted to the Iaşi Institute of Gastroenterology and Hepatology between August 2014 and February 2015 only 80 who met the eligibility criteria were enrolled and completed the study. Blood samples for routine tests and serum ammonia were collected from all patients on the day of PHES evaluation. Results: In the study group (n = 80) mean age was 57.7 ± 8.5 years, and the average number of years of education was 11.2 ± 2.7. The main causes of cirrhosis were alcohol consumption (31 patients - 38.8%), hepatitis C virus infection (29 patients - 36.3%) and hepatitis B virus infection (17 patients - 21.3%). Age, number of years of education, severity of liver disease (measured by using Child-Pugh and MELD scores) and some biological constants (albumin, bilirubin, International Normalized Ratio- INR) were significantly correlated (p <0.05) with most psychometric tests. Conclusions: PHES is a practical, objective and useful method for the diagnosis of MHE. Demographic and biological factors correlated with the results of the psychometric test. The PHES requires standardization before applying it in Romanian cirrhotic patients.

Author Biographies

  • M.A. BADEA, University of Medicine and Pharmacy “Grigore T. Popa”- Iasi

    Faculty of Medicine
    Department of Medical Specialties (I)
    Institute of Gastroenterology and Hepatology Iasi

  • Cristina CIJEVSCHI-PRELIPCEAN, University of Medicine and Pharmacy “Grigore T. Popa”- Iasi

    Faculty of Medicine
    Department of Medical Specialties (I)
    Institute of Gastroenterology and Hepatology Iasi

  • Catalina MIHAI, University of Medicine and Pharmacy “Grigore T. Popa”- Iasi

    Faculty of Medicine
    Department of Medical Specialties (I)
    Institute of Gastroenterology and Hepatology Iasi

  • Iolanda POPA, University of Medicine and Pharmacy “Grigore T. Popa”- Iasi

    Faculty of Medicine
    Department of Medical Specialties (I)
    Institute of Gastroenterology and Hepatology Iasi

  • V.L. DRUG, University of Medicine and Pharmacy “Grigore T. Popa”- Iasi

    Faculty of Medicine
    Department of Medical Specialties (I)
    Institute of Gastroenterology and Hepatology Iasi

References

1. Vilstrup et al. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatol 2014; 60(2): 715-735.
2. Bajaj JS. Minimal hepatic encephalopathy matters in daily life. World J Gastroenterol 2008; 14(23): 3609-3615.
3. Simon-Talero M, Ventura M, Cordoba J. Minimal hepatic encephalopathy. In: Gines P, Forns X, Fernandez J, Crespo G, Rodes J, Arroyo V. Therapy in Liver Diseases 2013; Barcelona: Elsevier Doyma. 20: 151-157.
4. Badea MA, Cijevschi Prelipcean C, Mihai C, Drug V. Current concepts in minimal hepatic encephalopathy. Rev Med Chir Soc Med Nat Iasi 2015; 119(1): 9-17.
5. Randolph C et al. International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN). Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines. Liver Int 2009; 29(5): 629-635.
6. Weissenborn K, Ennen JC, Schomerus H, Rückert N, Hecker H.Neuropsychological characterization of hepatic encephalopathy. J Hepatol 2001; 34(5): 768-773.
7. Seo YS, Yim SY et al. Psychometric Hepatic Encephalopathy Score for the detection of minimal hepatic encephalopathy in Korean patients with liver cirrhosis. J Gastroenterol Hepatol 2012; 27: 1695–1704.
8. Duarte-Rojo A, Estradas J, Hernández-Ramos R, Ponce-de-León S, Córdoba J, Torre A. Validation of the Psychometric Hepatic Encephalopathy Score (PHES) for Identifying Patients with Minimal Hepatic Encephalopathy. Dig Dis Sci 2011; 56:3014–3023.
9. Wunsch E, Koziarska D, Kotarska K, Nowacki P, Milkiewicz P. Normalization of the psychometric hepatic encephalopathy score in polish population. A prospective, quantified electroencephalography study. Liver Int. 2013; 33(9): 1332-1340.
10. Romero Gómez M, Córdoba J, Jover R, del Olmo J et al. Normality tables in the Spanish population for psychometric tests used in the diagnosis of minimal hepatic encephalopathy. Med Clin (Barc) 2006; 127(7): 246-249.
11. Amodio P, Campagna F, Olianas S, Iannizzi P. et al. Detection of minimal hepatic encephalopathy: normalization and optimization of the Psychometric Hepatic Encephalopathy Score. A neuropsychological and quantified EEG study. J Hepatol 2008; 49(3): 346-353.
12. Weissenborn K. PHES: one label, different goods?! J Hepatol 2008; 49(3): 308-312.

Additional Files

Published

2015-06-30

Issue

Section

INTERNAL MEDICINE - PEDIATRICS